celastrol has been researched along with Chondrosarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, M; Li, J; Mao, N; Miao, X; Shi, Z; Wang, C; Wu, J; Wu, Y; Yuan, J | 1 |
1 other study(ies) available for celastrol and Chondrosarcoma
| Article | Year |
|---|---|
Celastrol inhibits chondrosarcoma proliferation, migration and invasion through suppression CIP2A/c-MYC signaling pathway.
Topics: Apoptosis; Autoantigens; bcl-2-Associated X Protein; Caspase 8; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Chondrosarcoma; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Neoplasm Invasiveness; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Triterpenes | 2017 |